A Long-term Follow-up Study of Patients Who Received MB-105

Starting soon

Conditions studied: Any Patient Treated With MB-105

In brief

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

Key facts

Study ID

NCT07340814

Run by

March Biosciences Inc

People needed

40

Starts

2026-02-27

Expected to finish

2040-10-15

Last updated by the study team

2026-01-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Received MB-105 Signed informed consent Agree to transfer of samples from previous study Able to comply with study requirements

You may not qualify if…

• N/A

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.